Sleeping Pills Were Easier to Quit When the Taper Was Hidden

CATEGORY: SLEEP & RECOVERY

It’s 2 a.m., the pill bottle is in the bathroom cabinet, and one thought drowns out the clock: without it, there’s no sleep tonight. That fear is exactly what a team at UCLA and the Veterans Affairs health system set out to disarm. In their trial, 73% of older adults who’d used prescription sleeping pills for months or years were off them entirely six months later, compared with 59% who went through a standard quitting program.¹

Capsules That Quietly Lost Their Strength

The trial enrolled 188 adults aged 55 and older. All of them regularly took benzodiazepine receptor agonists, the family of prescription sleep drugs that includes zolpidem, temazepam, lorazepam, and alprazolam. Everyone got the same foundation: eight one-on-one sessions of cognitive behavioral therapy for insomnia, a structured retraining of sleep habits and sleep beliefs, plus a nine-week step-down off the medication. The difference sat inside the capsules. One group followed an ordinary taper and knew its schedule. The other swallowed look-alike capsules in which inert filler gradually replaced the drug, so nobody could tell which nights still held medication. A computer made the group assignments before anyone met a therapist.¹

Why Hide the Taper at All?

The researchers built the study around a specific hunch. Part of a sleeping pill’s grip, they reasoned, is expectation: if you know tonight’s dose is smaller, you brace for a bad night, and the bracing itself can wreck your sleep. You can’t brace for a cut you can’t see. The masked group also worked through exercises designed to drive the lesson home, noticing night after night that their sleep had survived on less drug than they thought. The result came in just as the team had predicted it would.¹

Most Were Off, and Sleep Held Up

One week after the program ended, 88% of the hidden-taper group had stopped completely, versus 67% with the open taper. By six months the figures were 73% and 59%, or 64 of 87 people against 52 of 89. Just as telling, insomnia ratings improved by similar amounts in both groups. Quitting didn’t cost anyone’s sleep, on average. It got better. The honest limits: this was a midsize trial, run in one region, with mostly White participants, and the authors want the approach confirmed in larger and more diverse groups. What the trial can already say is that the standard route worked for most people, and hiding the taper helped a meaningful number more get free.¹

Key Takeaways

• Older adults who tapered off sleeping pills inside look-alike capsules, never knowing which nights still held drug, quit more often: 73% were off at six months versus 59% with a standard open taper.
• Insomnia scores improved in both groups, so stopping the medication didn’t worsen sleep on average.
• Both routes included individual insomnia therapy, and even the standard one got nearly 6 in 10 longtime users off the pills, a result many people on these drugs might not expect.
• The trial was midsize and regional, so the masked approach still needs confirmation in larger, more diverse groups.

References

1. Fung CH, Alessi C, Martin JL, et al. Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial. JAMA Internal Medicine. 2024;184(12):1448–1456. link